Search

Samuel Achilefu, Ph.D., nationally recognized for expertise in molecular imaging and its application in treating human diseases, has been selected inaugural Chair to launch a new Department of Biomedical Engineering (BME) at UT Southwestern Medical Center.

COVID-19 impairs the function of the body’s microvascular system with an intensity that corresponds to the severity of disease, suggests a new study by an international consortium, including UT Southwestern Medical Center.

A team of researchers at UT Southwestern Medical Center’s Touchstone Diabetes Center have successfully used CRISPR gene editing to turn fat cells normally used for storage into energy-burning cells.

UT Southwestern researchers have identified a new mechanism by which stress causes cells to stop dividing.

An international panel of experts from four renowned diabetes research centers, including UT Southwestern Medical Center, has reviewed current literature and is recommending a pivotal change in treatment of Type 2 diabetes to focus on obesity first and glucose control second.

Immobilization is the most common treatment, and yet, until recently, it was unknown exactly why this technique worked to advance healing.

An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target.

UT Southwestern Medical Center scientists have discovered a protein that works with others during development to put the brakes on cell division in the heart, they report today in Nature.

Three anticonvulsant drugs commonly used to stop prolonged, potentially deadly seizures each work equally well, according to a national study involving physicians at UT Southwestern.

Surgeons at UT Southwestern have developed and analyzed the benefits of a cutting-edge technique that provides patients with facial paralysis the ability to close their eyes.